Taysha Gene Therapies, Inc. Common Stock TSHA

$4.11 +4.31% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-11 View →
8-K 8-K 2026-08-11 View →
4 Insider transaction 2026-07-10 View →
8-K 8-K 2026-06-25 View →
424B5 424B5 2026-06-25 View →
424B5 424B5 2026-06-24 View →
8-K 8-K 2026-06-22 View →
4 Insider transaction 2026-06-02 View →
4 Insider transaction 2026-06-02 View →
4 Insider transaction 2026-06-02 View →
4 Insider transaction 2026-06-02 View →
8-K 8-K 2026-06-02 View →
10-Q 10-Q 2026-05-06 View →
8-K 8-K 2026-05-06 View →
DEF 14A DEF 14A 2026-04-22 View →
4 Insider transaction 2026-04-13 View →
10-K 10-K 2026-03-19 View →
8-K 8-K 2026-03-19 View →
4 Insider transaction 2026-02-06 View →
4 Insider transaction 2026-01-27 View →
4 Insider transaction 2026-01-27 View →
4 Insider transaction 2026-01-27 View →
4 Insider transaction 2026-01-14 View →
4 Insider transaction 2026-01-14 View →
4 Insider transaction 2026-01-14 View →
4 Insider transaction 2025-12-01 View →
8-K 8-K 2025-11-04 View →
10-Q 10-Q 2025-11-04 View →
8-K 8-K 2025-10-16 View →
8-K 8-K 2025-10-09 View →
8-K 8-K 2025-10-02 View →
4 Insider transaction 2025-09-12 View →
4 Insider transaction 2025-08-22 View →
4 Insider transaction 2025-08-22 View →
10-Q 10-Q 2025-08-12 View →
8-K 8-K 2025-08-12 View →
4 Insider transaction 2025-06-04 View →
4 Insider transaction 2025-06-04 View →
4 Insider transaction 2025-06-04 View →
4 Insider transaction 2025-06-04 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$4.11
Market Cap
$1.28 billion
52-Week Range
$2.71 – $7.30
Average Volume
4.36 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.